Sorry, you need to enable JavaScript to visit this website.

Sign Up For Mailing List Button

Donate to Genetic Alliance

Disease Search Button

Bray Patrick-Lake

Facebook icon
Google+ icon
Twitter icon
LinkedIn icon icon
Digg icon

Bray Patrick-Lake, MD, MSC
Director of Stakeholder Engagement, Duke Clinical Research Institute

As Director of Stakeholder Engagement and Research Together program lead, Bray Patrick-Lake supports efforts to actively engage patients, health advocacy organizations, and other stakeholders in Duke Clinical Research Institute’s local and national research programs. She has led extensive efforts through the Clinical Trials Transformation Initiative to incorporate patient voice into clinical trial design, conduct, oversight, and regulatory frameworks, as well as improvement of the clinical trial enterprise. She currently serves as the DCRI Coordinating Center’s engagement lead for the Project Baseline study and NIH’s Environmental Influences on Child Health Outcomes program. In 2015 – 2016, she co-chaired the Advisory Committee to the NIH Director’s Working Group responsible for authoring the vision and roadmap to launch the Precision Medicine Initiative Cohort Program. She served as the Interim Director of Engagement for several months after program launch. She currently serves on the National Academies of Science, Engineering, and Medicine (NASEM) Board on Health Sciences Policy, the All of Us National Advisory Panel, and leads engagement work at Duke’s Coordinating Center for NIH’s Environmental Influences on Child Health Outcomes (ECHO) program. She recently also served on the NASEM Committee that developed recommendations and a framework for the Return of Individual Research Results.

Twitter icon
Facebook icon
LinkedIn icon
Google+ icon
YouTube icon
RSS icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.